Dr. Braunschweig on Mitigating the Toxicities of CAR T-Cell Therapy in Lymphoma
Ira Braunschweig, MD, discusses mitigating the toxicities that are associated with CAR T-cell therapy in lymphoma.
Dr. Braunschweig on Selecting Between Transplant and CAR T-Cell Therapy in DLBCL
Ira Braunschweig, MD, discusses factors to consider when selecting between autologous stem cell transplant, allogeneic stem cell transplant, and CAR T-cell therapy in diffuse large B-cell lymphoma.
2 Clarke Drive Cranbury, NJ 08512